FLUOROQUINOLONES
FLUOROQUINOLONES
- Oral agents.
- Have long post-antibiotic effect (PAE).
MOA:
- Acts by inhibiting DNA gyrase (topoisomerase II) & topoisomerase IV –> DNA replication inhibition.
Classification of fluoroquinolones:
- Based on spectrum of antibacterial activity:
1st generation:
- Narrow spectrum; mainly gram-negative.
- Norfloxacin, lomefloxacin.
2nd generation:
- Ciprofloxacin & ofloxacin.
3rd generation:
- More active against gram-positive.
- Levofloxacin, gatifloxacin, pefloxacin, sparfloxacin.
4th generation:
- Broadest spectrum.
- Moxifloxacin, fleroxacin, garenoxacin, gemifloxacin & trovafloxacin.
Pharmacokinetics:
- Good oral bioavailability (except norfloxacin).
- Levofloxacin – 100% bioavailability.
- Multivalent cations interfere with absorption (like tetracycline).
Metabolism & excretion:
- Hepatic metabolism & biliary excretion –
- Moxifloxacin & trovafloxacin.
- Excreted by both renal & hepatic route –
- Sparfloxacin & pefloxacin.
- Excreted by tubular secretion –
- All other drugs (ciprofloxacin, gatifloxacin, levofloxacin, lomefloxacin, norfloxacin & ofloxacin).
- Probenecid inhibits tubular secretion.
Half-lives:
- Sparfloxacin, moxifloxacin & trovafloxacin – Long half-lives.
- Sparfloxacin – Longest half-life among fluoroquinolones.
- Hence, administered once daily orally.
Dose adjustment:
- Required in renal disease for all fluoroquinolones, except pefloxacin, moxifloxacin & trovafloxacin (mnemonic: PMT).
Individual drug description:
Levofloxacin:
- L-isomer of ofloxacin.
Sparfloxacin:
- Greater activity against gram-positive organisms; Ineffective against Pseudomonas.
Clinical Uses:
- Greatest activity against Pseudomonas (maximum with ciprofloxacin).
Uses of 1st generation drugs:
- Norfloxacin – Useful in UTI.
- Urinary concentration is bactericidal; Ineffective for systemic use.
Uses of 2nd generation drugs:
- Ciprofloxacin – DOC for prophylaxis & treatment of anthrax & for prophylaxis of meningococcal meningitis.
Combination drugs:
- Ciprofloxacin & ofloxacin – Effective against gonorrhea & other gram-negative organisms including Pseudomonas.
- Ciprofloxacin & levofloxacin – Only fluoroquinolones effective against Pseudomonas.
- Levofloxacin -Effective against atypical microorganism (mycoplasma) infection.
“Respiratory fluoroquinolones”:
- Levofloxacin, gatifloxacin, gemifloxacin & moxifloxacin.
- Due to their enhanced activity against gram-positive & atypical organisms (chlamydia, mycoplasma & legionella).
Moxifloxacin & trovafloxacin:
- Widest spectrum including gram (-ve) & gram (+ve) micro-organisms, including anaerobes.
Ciprofloxacin, levofloxacin &moxifloxacin:
- Effective in tuberculosis.
- For prophylaxis of neutropenic patients.
Finafloxacin –
- Recently approved for topical treatment of acute otitis externa caused by Pseudomonas & Staphylococcus.
- Used for adolescent cystic fibrosis with pulmonary exacerbations.
Contraindications:
- Epilepsy.
- In children less than 18 yrs old & in pregnancy – Due to cartilage problems.
Adverse effects:
- GI distress (most common).
- CNS side effects (headache & dizziness; rarely seizures).
- Tendinitis resulting in tendon rupture (rarely in adults).
- Phototoxicity (maximum incidence with lomefloxacin & sparfloxacin).
- Sparfloxacin & gatifloxacin prolong QTc interval.
Withdrawn fluoroquinolones:
- Temafloxacin – Immune hemolytic anemia.
- Gatifloxacin – Dysglycemic effects.
- Trovafloxacin – Hepatotoxicity.
- Grepafloxacin – Cardiotoxicity, arrhythmias due to increasing QT interval.
- Clinafloxacin – Phototoxicity.
- Recent FDA warning on peripheral neuropathy by fluoroquinolones.
Drug interactions:
With methylxanthines (theophylline):
- Fluoroquinolones (particularly ciprofloxacin or pefloxacin) increase plasma methylxanthines concentration (Theophylline).
- Enhances theophylline toxicity.
With NSAID’s:
- NSAIDs increase CNS toxicity (seizures) of these drugs.
- Hence, contra-indicated in epilepsy.
Exam Important
- Fluoroquinolones have long post-antibiotic effect (PAE).
- Fluoroquinolones act by inhibiting DNA gyrase (topoisomerase II) & topoisomerase IV –> DNA replication inhibition.
- 1st generation fluoroquinolones (Norfloxacin lomefloxacin) are narrow spectrum, mainly gram-negative.
- Ciprofloxacin & ofloxacin are 2nd generation fluoroquinolones.
- 3rd generation fluoroquinolones are more active against gram-positive.
- Levofloxacin, gatifloxacin, pefloxacin, sparfloxacin belong with 3rd generation fluoroquinolones.
- Broadest spectrum fluoroquinolones are 4th generation flouroquinolones.
- Moxifloxacin & trovafloxacin is hepatic metabolism & biliary excretion.
- Sparfloxacin & pefloxacin is excreted by both renal & hepatic route.
- All other drugs (ciprofloxacin, gatifloxacin, levofloxacin, lomefloxacin, norfloxacin & ofloxacin) excreted by tubular secretion.
- Sparfloxacin, moxifloxacin & trovafloxacin exhibit long half-lives, administered once daily orally.
- Sparfloxacin is longest half-life among fluoroquinolones.
- Dose adjustment required in renal disease for all fluoroquinolones, except pefloxacin, moxifloxacin & trovafloxacin (mnemonic: PMT).
- Norfloxacin is useful in UTI, urinary concentration is bactericidal.
- Ciprofloxacin is DOC for prophylaxis & treatment of anthrax & meningococcal meningitis prophylaxis.
- Ciprofloxacin & ofloxacin is effective against gonorrhea.
- Ciprofloxacin & levofloxacin is only fluoroquinolones effective against Pseudomonas.
- “Respiratory fluoroquinolones” include Levofloxacin, gatifloxacin, gemifloxacin & moxifloxacin, due to their enhanced activity against gram-positive & atypical organisms (chlamydia, mycoplasma & legionella).
- Moxifloxacin & trovafloxacin is widest spectrum including gram (-ve) & gram (+ve) micro-organisms, including anaerobes.
- Ciprofloxacin, levofloxacin & moxifloxacin are effective in tuberculosis.
- Finafloxacin is approved for topical treatment of acute otitis externa, caused by Pseudomonas & Staphylococcus.
- Fluoroquinolones are contraindicated in epilepsy.
- Maximum incidence of phototoxicity is with lomefloxacin & sparfloxacin.
- Sparfloxacin & gatifloxacin prolong QTc interval.
- Grepafloxacin is cardiotoxicity, arrhythmias increasing QT interval.
- Recent FDA warning on peripheral neuropathy by fluoroquinolones.
- Fluoroquinolones (particularly ciprofloxacin or pefloxacin) increase plasma methylxanthines concentration (Theophylline), enhances theophylline toxicity.
- NSAID’s with fluoroquinolones, NSAIDs increase CNS toxicity (seizures) of these drugs, hence contra-indicated in epilepsy.
Don’t Forget to Solve all the previous Year Question asked on FLUOROQUINOLONES
Click Here to Start Quiz
Click Here to Start Quiz


